Skip to main content

Animations

MJFF Publications

3961 - 3970 of 6514 Results
Title
Year
  • Year
  • 2017
  • 2017
  • 2018
  • 2020
  • 2012
  • 2023
  • 2024
  • 2019
  • 2017
  • 2011
  • Summary Details
    OPEN
    Title: 4R-Cembranoid Improves Outcomes after 6-Hydroxydopamine Challenge in Both In vitro and In vivo Models of Parkinson's Disease
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2017.00272
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Human LRRK2 G2019S mutation represses post-synaptic protein PSD95 and causes cognitive impairment in transgenic mice
    Journal Name: Neurobiology of Learning and Memory
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nlm.2017.05.001
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons
    Journal Name: The American Journal of Human Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ajhg.2018.10.018
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic Mice
    Journal Name: Molecular Therapy Nucleic Acids
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.omtn.2020.06.027
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Web-Based Assessment of Visual and Visuospatial Symptoms in Parkinson’s Disease
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2012/564812
    Citation Count: 4
  • Summary Details
    OPEN
    Title: MAPT allele and haplotype frequencies in Nigerian Africans: Population distribution and association with Parkinson's disease risk and age at onset
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105517
    Citation Count: 3
  • Summary Details
    OPEN
    Title: N-acetylation of α-synuclein enhances synaptic vesicle clustering mediated by α-synuclein and lysophosphatidylcholine
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.97228.3
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Defining α-synuclein species responsible for Parkinson’s disease phenotypes in mice
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1074/jbc.ra119.007743
    Citation Count: 114
  • Summary Details
    OPEN
    Title: Ligand Dependent Switch from RXR Homo- to RXR-NURR1 Heterodimerization
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00216
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets
    Journal Name: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbadis.2011.07.004
    Citation Count: 61
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.